Aethlon Medical (AEMD) Equity Average (2016 - 2024)
Historic Equity Average for Aethlon Medical (AEMD) over the last 14 years, with Q4 2024 value amounting to $5.2 million.
- Aethlon Medical's Equity Average fell 4225.92% to $5.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.2 million, marking a year-over-year decrease of 4225.92%. This contributed to the annual value of $10.4 million for FY2024, which is 3501.75% down from last year.
- Latest data reveals that Aethlon Medical reported Equity Average of $5.2 million as of Q4 2024, which was down 4225.92% from $7.4 million recorded in Q3 2024.
- In the past 5 years, Aethlon Medical's Equity Average registered a high of $23.8 million during Q3 2021, and its lowest value of $5.2 million during Q4 2024.
- Over the past 5 years, Aethlon Medical's median Equity Average value was $13.3 million (recorded in 2020), while the average stood at $13.3 million.
- In the last 5 years, Aethlon Medical's Equity Average soared by 266780.55% in 2020 and then plummeted by 5863.89% in 2024.
- Over the past 5 years, Aethlon Medical's Equity Average (Quarter) stood at $12.5 million in 2020, then soared by 73.83% to $21.7 million in 2021, then decreased by 14.52% to $18.6 million in 2022, then crashed by 51.73% to $9.0 million in 2023, then plummeted by 42.26% to $5.2 million in 2024.
- Its Equity Average stands at $5.2 million for Q4 2024, versus $7.4 million for Q3 2024 and $7.2 million for Q2 2024.